To address the severe shortage of academic pediatric endocrinologists, this Training Program will take advantage of the important new opportunities for advancing diabetes and endocrine research in children provided by such recent scientific advances as the Human Genome Project, islet transplantation and biomechanical and bio-engineered islets, and the NIH roadmap plans to transform GCRC programs for patient-oriented research into Clinical Translational Science Awards. The Program will support Trainees during up to 2 years of research training at the fellowship level. The Training faculty includes 34 scientific mentors from the Children's Hospital and the UPenn School of Medicine who have outstanding credentials and active funded research programs and well-established training records. These mentors will supervise Trainees in basic laboratory research and/or patient-oriented and translational research projects related to diabetes and endocrine disorders in children. Research opportunities will include several areas of basic research (?-Cell Function, Hormone Action, Mechanisms of Disease, Endocrine Physiology, and transcriptional Regulation). Patient-oriented research opportunities will include Translational Research, Disease Mechanisms, Pathophysiology, Diabetes Complications, Genetics, Clinical Trials, Metabolic Syndrome, Nutrition, and Epidemiology. The Program includes multiple interactions for Trainees with basic and clinical research and training in all aspects of research, including biostatistics, bioethics, molecular biology, etc. The Program is strongly supported by access to a superb range of institutional resources at Children's Hospital and UPenn, including the CHOP GCRC and the UPenn DERC. Request is made to continue support for 3 fellow slots and 2 student slots in this Program each year.

Public Health Relevance

The long-term goal of this T32 Training Program renewal is to develop a new generation of pediatric endocrinologists who will be equipped to carry out innovative and scientifically rigorous patient-oriented and laboratory-based research in diabetes and endocrine disorders of children. This will address a major public health need which is the critical shortage of academic pediatric endocrinologists in diabetes and endocrinology research. This shortage has been emphasized by the American Diabetes Association, the Juvenile Diabetes Research Foundation, and the Pediatric Academic Societies.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-4 (M2))
Program Officer
Castle, Arthur
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital of Philadelphia
United States
Zip Code
Sarezky, Margaret D; Corwin, Daniel J; Harrison, Victor S et al. (2016) Hyperthyroidism Presenting With Pathologic Fractures. Pediatrics 137:e20150169
Calabria, Andrew C; Charles, Lawrenshey; Givler, Stephanie et al. (2016) Postprandial Hypoglycemia in Children after Gastric Surgery: Clinical Characterization and Pathophysiology. Horm Res Paediatr 85:140-6
Mitchell, Jonathan A; Chesi, Alessandra; Elci, Okan et al. (2016) Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. J Bone Miner Res 31:789-95
Roizen, Jeffrey D; Danzig, Jennifer; Groleau, Veronique et al. (2016) Resting Energy Expenditure Is Decreased in Pseudohypoparathyroidism Type 1A. J Clin Endocrinol Metab 101:880-8
Harrison, V Sanoe; Rustico, Stacy; Palladino, Andrew A et al. (2016) Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen. Pediatr Diabetes :
Weber, David R; Coughlin, Curtis; Brodsky, Jill L et al. (2016) Low bone mineral density is a common finding in patients with homocystinuria. Mol Genet Metab 117:351-4
Katz, Lorraine E Levitt; Gralewski, Kevin A; Abrams, Pamela et al. (2016) Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents. Pediatr Diabetes 17:77-86
George, Sobenna; Weber, David R; Kaplan, Paige et al. (2015) Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience. J Clin Endocrinol Metab 100:4163-71
Lord, Katherine; Radcliffe, Jerilynn; Gallagher, Paul R et al. (2015) High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism. J Clin Endocrinol Metab 100:4133-9
Weber, David R; Haynes, Kevin; Leonard, Mary B et al. (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care 38:1913-20

Showing the most recent 10 out of 40 publications